Fig. 3From: Interaction of arbekacin with dialysis membraneProtocol for the clinical trial. Arbekacin was administered via intravenous infusion over 30 min. At 10 min after the start of hemodialysis, blood was circulated without dialysate in order to obtain the ultrafiltrate. AN69 sulfonated polyacrylonitrileBack to article page